Sr. Manager / Associate Director, Strategy and Program Management

About Eidos Therapeutics & BridgeBio Pharma

Eidos Therapeutics, an affiliate of BridgeBio Pharma, is a Phase 3 developmental-stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR. We seek to treat this well-defined family of diseases at their collective source by stabilizing TTR. Our investigational product, acoramidis (AG10), is an orally administered small molecule designed to potently stabilize TTR, a potentially best-in-class treatment aiming to halt the progression of ATTR diseases.

BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company has built a portfolio of 30+ drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas including genetic dermatology, precision oncology, cardiology, endocrinology, neurology, pulmonology, and renal disease, with two approved drugs. 

Our focus on scientific excellence and rapid execution aims to translate today’s discoveries into tomorrow’s medicines. We have U.S. offices in San Francisco, Palo Alto, and Raleigh, with small satellites in other parts of the country. We also have international offices in Montreal, Canada, and Zurich, Switzerland, and are expanding across Europe. 

To learn more about our story and company culture, visit us at eidostx.com/ | https://bridgebio.com

Who You Are

The Strategy and Program Management role will join a lean team that drives forward movement of BridgeBio’s cardio-renal division, with a focus on Eidos. This role is responsible for generating strategic insights and long-term planning for acoramidis, a rare cardiovascular disease for ATTR-CM (Transthyretin Amyloid Cardiomyopathy). This individual must develop a thorough understanding of the unmet medical need, ATTR journals and publications, and the scientific and therapeutic landscape. The role will include scientific diligence, competitive intelligence, project management of ongoing lifecycle initiatives, business case evaluation, and managing the broader project team to achieve program goals.

Responsibilities

• Synthesis of large amounts of scientific data, papers, and clinical trials within the ATTR-CM space and providing strategic insights on implications to the business 
• Competitive intelligence evaluating earnings calls and analyst reports to understand competitor activity and impact to BridgeBio. 
• Attendance at major congresses to further understand scientific progress and competitor activity within the space and synthesize findings for the broader team 
• Project management of key lifecycle opportunities 
• Coordination of internal meetings, minutes, and driving follow-ups  
• Guide team members and colleagues toward a specific goal or outcome while gaining exposure across all functions within the company  
• Business case development and NPV modelling  
• Demonstrated excellence at managing diverse stakeholders and driving for results 

No matter your role at BridgeBio, successful team members are:

• Patient Champions, who put patients first and uphold strict ethical standards
• Entrepreneurial Operators, who drive toward practical solutions and have an ownership mindset
• Truth Seekers, who are detailed, rational, and humble problem solvers
• Individuals Who Inspire Excellence in themselves and those around them
• High-quality executors, who execute against goals and milestones with quality, precision, and speed

Education, Experience & Skills Requirements

• Passion for getting lifesaving medicines into the hands of patients as quickly and efficiently as is humanly possible 
• University-level or Graduate School focus within the healthcare business/ life sciences industry 
• 3-5+ years of experience in life sciences consulting/ investment banking or healthcare business preferred 
• Excellent project management skills and ability to handle multiple projects simultaneously 
• Ability to work independently and as part of a team 
• Must be comfortable with ambiguity 
• Fast (extremely fast) learner 
• Strong communication skills 

What We Offer

• Patient Days, where we are fortunate to hear directly from individuals living with the conditions we are seeking to impact throughout the year and learn how we can improve our efforts
• A culture inspired by our values: put patients first, think independently, be radically transparent, every minute counts, and let the science speak
• An unyielding commitment to always putting patients first. Learn more about how we do this here
• A de-centralized model that enables our program teams to focus on advancing science and helping patients. Our affiliate structure is designed to eliminate bureaucracy and put decision-making power in the hands of those closest to the science
• A place where you own the vision – both for your program and your own career path
• A collaborative, fast-paced, data-driven environment where we inspire ourselves and each other to always perform at the top of our game
• Access to learning and development resources to help you get in the best professional shape of your life
• Robust and market-competitive compensation & benefits package (Base, Performance Bonus, Equity, health, welfare & retirement programs)
• Flexible PTO
• Rapid career advancement for strong performers
• Potential ability to work on multiple BridgeBio Pharma programs across multiple therapeutic areas over time 
• Partnerships with leading institutions
• Commitment to Diversity, Equity & Inclusion